Biogen Inc. (Nasdaq: BIIB) will present data from its Alzheimer's disease portfolio at the Alzheimer's Association International Conference (AAIC) 2026 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE